Researchers sought to assess the short-term benefit and risk of ticagrelor with aspirin in patients with acute mild-moderate ischemic stroke or high-risk transient ischemic attack.
AXS-07 is an oral agent that consists of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug, and rizatriptan, a 5-HT1B/1D agonist.
Transcranial direct current stimulation (tDCS) is effective and safe for migraine.
Migraine is associated with an increased risk for burning mouth syndrome (BMS).
Researchers sought to assess the qualitative effects of COVID-19 on patients with migraine who never tested positive for or been diagnosed with COVID-19.
Yoga therapy may reduce the frequency of headaches for people with migraine.
For patients with vestibular migraine (VM), the mean age of headache and vertigo onset is 25 and 39 years.
Women with chronic migraine (CM) report significantly more days with naps than healthy controls, and nap duration is associated with headache severity.
Presenting at the 2022 AAN Annual Meeting, researchers described the characteristics of patients diagnosed with migraine and benign paroxysmal positional vertigo.
Presenting at the 2022 AAN Annual Meeting, researchers assessed the safety and efficacy of monthly erenumab among adult patients with chronic migraine with Asian ancestry.
